HomeTagsSAN FRANCISCO and SUZHOU

SAN FRANCISCO and SUZHOU

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics